Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsPreschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.
Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.
An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.
In patients with cancer receiving immune checkpoint inhibitor therapy, osteoarthritis is linked to the risk for inflammatory arthritis immune-related adverse events.
Researchers evaluate the impact of allogeneic stem cell transplantation in chronic myelomonocytic leukemia across BLAST and BLAST-Mol clinical risk models.
1.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
2.
More Data Back Teclistamab for Autoimmune Disease
3.
Many women undergo annual mammography, despite biennial screening recommendations
4.
For the first time in humans, a chemotherapy drug reaches the brain.
5.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
1.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
2.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
3.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
4.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
5.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Understanding Platelet Disorders
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation